Literature DB >> 6712866

Reduction of antipyrine clearance in psoriasis.

J R Marsden, F M Williams, B Keys, M D Rawlins, S Shuster.   

Abstract

Antipyrine clearance was determined in 41 psoriatics and age-sex matched controls, using sequential measurements of salivary concentration. Antipyrine clearance and elimination rate constant were less in psoriatics (P less than 0.05) and apparent volumes of distribution were similar. These differences were greater between female psoriatics and controls (P less than 0.025; P less than 0.05) and the differences between male psoriatics and controls were not significant. Correlation of simultaneous measurements of saliva and plasma antipyrine concentration in six psoriatics and age-sex matched controls showed no differences between the two groups. We conclude that antipyrine clearance is reduced in psoriasis but the underlying mechanism is unclear.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712866      PMCID: PMC1463382          DOI: 10.1111/j.1365-2125.1984.tb02349.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.

Authors:  R E Vestal; A H Norris; J D Tobin; B H Cohen; N W Shock; R Andres
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Assessment of antipyrine kinetics by measurement in saliva.

Authors:  H S Fraser; J C Mucklow; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

3.  Antipyrine clearance in psoriasis.

Authors:  P H Chapman; B Keys; M D Rawlins; C Moss; S Shuster
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-03

4.  Aryl hydrocarbon hydroxylase activity and psoriasis.

Authors:  M J Finnen; S Shuster; C M Lawrence; M D Rawlins
Journal:  Biochem Pharmacol       Date:  1983-06-01       Impact factor: 5.858

  4 in total
  1 in total

1.  Antipyrine clearance and metabolism in patients with psoriasis.

Authors:  K Kubota; T Ishizaki; K Chiba; A Takagi; A Nakagawa; K Nakamura
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.